URGENT UPDATE: The Australian stock market is buzzing as 4DMedical Ltd (ASX: 4DX) has skyrocketed an astonishing 665% in just two months, turning an initial investment of $10,000 into a staggering $76,521. This remarkable surge comes on the heels of significant announcements that have captivated investors.
Since the market closed on July 9, 2023, the All Ordinaries Index (ASX: XAO) has climbed 4.0%, but 4DMedical’s explosive growth has eclipsed those gains. On July 9, shares were priced at just 23 cents, allowing investors to purchase 43,478 shares. As of last Friday, shares closed at $1.76 each, marking a meteoric rise.
What’s driving this remarkable ascent? Over the past two months, 4DMedical has announced key developments that have ignited investor interest. On August 1, 2023, the stock surged 27.1% following news of a $10 million investment from health imaging leader Pro Medicus Ltd (ASX: PME). CEO Andreas Fouras expressed excitement, stating,
“Pro Medicus is a global leader in healthcare, and we are thrilled to receive their support at this pivotal moment in our journey.”
The momentum continued when, on September 1, shares jumped 36.0% after receiving clearance from the U.S. Food and Drug Administration (FDA) for their innovative CT:VQ software, designed for lung health analysis. Just two days later, on September 3, the stock soared another 50.0% after the Centers for Medicare & Medicaid Services (CMS) announced that it would reimburse $650.50 per scan effective immediately.
The excitement didn’t stop there. On September 8, shares surged an additional 49.5% following announcements of new agreements with major institutions, including the Royal Melbourne Hospital, Spectrum Medical Imaging, and AstraZeneca. This series of successful developments has not only driven the stock price higher but has also positioned 4DMedical as a formidable player in respiratory imaging technology.
Investors are closely monitoring the company as it prepares to capitalize on its FDA clearance and reimbursement arrangements. With significant growth potential in the healthcare sector, especially amid rising demand for advanced imaging solutions, 4DMedical is emerging as a stock to watch.
As the market reacts to these developments, traders and investors alike are eager to see how high 4DMedical shares can soar. Will this trend continue, or are we witnessing a peak? Stay tuned as this story unfolds, and consider what this means for your investment strategy moving forward.
The remarkable journey of 4DMedical illustrates how swiftly fortunes can change in the stock market, making it a compelling topic for investors and enthusiasts alike. Share this news to keep your network informed about this incredible financial turnaround!
